PROSPECTS AND OPPORTUNITIES
Topical analgesics sustains market post-infection demand surge
Retail value sales of analgesics are expected to grow over the forecast period. As the wave of infectious disease outbreaks subsides, demand for systemic analgesics - such as oral painkillers - is expected to gradually stabilise.
Topical analgesics boosted by active seniors and lifestyle changes as OTC equivalents move beyond public health insurance
Japan’s topical analgesics/anaesthetic market is expected to maintain steady growth, driven by two key demographic and lifestyle shifts: the rising number of people suffering from shoulder and lower back pain, and the expansion of the active senior population. These trends are fuelling consistent demand for pain relief products, particularly those that offer convenience and targeted application.
Switch to OTC and self-medication expansion key to market growth
Japan’s healthcare policy is increasingly encouraging consumers to manage minor health issues independently, driven by the need to ease pressure on public insurance finances. This shift is reinforcing the importance of the over-the-counter (OTC) market, positioning it as a key player in everyday healthcare.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Japan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Japan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Japan report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Japan?
- Which are the leading brands in Analgesics in Japan?
- How are products distributed in Analgesics in Japan?
- How has the regulatory and operating environment for Analgesics changed in Japan?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Japan - Category analysis
KEY DATA FINDINGS
Self-medication awareness and price revisions boost analgesics
Topical analgesics thrive despite new product launches and price adjustments
Eve brand celebrates 50 years and adapts to international regulations
Topical analgesics sustains market post-infection demand surge
Topical analgesics boosted by active seniors and lifestyle changes as OTC equivalents move beyond public health insurance
Switch to OTC and self-medication expansion key to market growth
Consumer Health in Japan - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!